Posts Tagged ‘healthtech’
Biotech spin-out Ferryx secures seed funding
Bristol-based biotech startup, Ferryx, has raised £300k seed capital from Deepbridge Capital for further development of its innovative solution to common gut problems. Ferryx is a University of Bristol spin-out company that joined SETsquared Bristol in 2020 and has since won ‘Best Elevator Pitch’ at our Tech-Xpo 2021 Showcase. The company aims to tackle the…
Read MoreRadii Devices: Redefining prosthetics and orthotics
Following our member Radii Devices‘ recent grant funding success with Innovate UK’s Biomedical Catalyst fund, we had a chat with Founder and CEO, Joshua Steer, to find out about his journey from researcher to medtech startup… Radii Devices key facts Start date: April 2020 Market sector: Medtech Location: Engine Shed, Bristol Number of employees: 6 Company growth status: About…
Read MoreGenomeKey raise Innovate UK funding to drive life-saving next-gen sepsis diagnostic
Our member GenomeKey, has secured an Innovate UK Biomedical Catalyst research award of £950,000 towards faster diagnosis and treatment of sepsis, one of the world’s most deadly diseases. The funding will enable the Bristol-based research and development company to provide rapid bacterial species identification and antimicrobial profiling in the hospital, which will save lives, save money,…
Read MoregetUBetter invited to join NHS Innovation Accelerator
Dr. Carey McClellan, CEO of our member company getUBetter, has been invited to join the prestigious NHS Innovation Accelerator (NIA) as a Fellow. NIA was established in 2020 to support exceptional individuals to scale promising innovations across England’s NHS. getUBetter has experienced significant growth over the last 12 months and is now providing its digital self-management…
Read MoreFemtech startup LatchAid secures £1m seed funding
Our member LatchAid, an award winning breastfeeding and early parenthood support innovator, has closed its seed funding round with an ultra-competitive £510k Innovate UK Innovation Loan, bringing total investments to £1m, as testament to its ground-breaking technology and user traction. LatchAid was founded by Dr Chen Mao Davies, a R&D specialist who previously worked on the Oscar (Academy Award)…
Read MoreFluoretiQ announces the closure of £1.1 million funding round
Our member and University of Bristol spin-out, FluoretiQ, has today announced the completion of a £1.1 million, pre-series A investment. Their pioneering NANOPLEX technology is a 15-minute proprietary diagnostic platform for bacterial infections. The round was led by early-stage life science investors, Deepbridge Capital LLP, with significant participation from MAINStream, OION, SAIC and existing investors. This…
Read MoreFluoretiQ case study: Revolutionising bacterial diagnostics
To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with FluoretiQ Co-founder and CEO, Neciah Dorh… FluoretiQ Key Facts Start date: 2 March 2017 Market sector: Healthcare (Diagnostics) Location: Bristol Number of employees: 10…
Read MoreLatchAid case study: Using tech to support breastfeeding and motherhood
To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with LatchAid Founder and CEO, Dr. Chen Mao Davies… LatchAid Key Facts Start date: July 2018 Market sector: Femtech Location: Bristol Number of employees: 3 Amount…
Read MoreGenomeKey case study: Saving lives through early diagnosis of sepsis
To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with GenomeKey CEO, Michael Roberts… GenomeKey Facts Start date: August 2019 Market sector: Medtech/diagnostics Location: Bristol Number of employees: 9 growing to 12 and beyond Amount…
Read MoreNeuronostics reach final of global competition
Neuronostics, a SETsquared Bristol member, is one of four finalists for the Nature Spinoff Prize 2021. The finalists were chosen for their potential to translate world-leading scientific research into products and services that would have lasting impact on society. Neuronostics was co-founded by Professor John Terry and Dr Wessel Woldman in 2018. Since that time,…
Read More